New milestone for AlzeCure Pharma — Two major licensing deals in a month
07 juli 2026
Today ABG Sundal Collier Equity Research sat down with AlzeCure Pharma's CEO Martin Jönsson to discuss the company's recent momentum and plans going forward. Watch the full interview here! From clinical-stage pipeline to validated partnershipsAlzeCure Pharma is a Swedish pharmaceutical company...
-
New company at ABGSC - Qliro
2026-06-09 kl. 07:00
-
ABGSC Investor Days 21-22 May
2026-05-20 kl. 05:38
-
Event registration - ABGSC Investor Days seminar ...
2026-05-13 kl. 06:00